Market by Component, Deployment Mode, and Country Outlook | Forecast 2023-2030
Triton’s report insinuates that the pharmaceutical supply chain management market in the Middle East and Africa is projected to observe a CAGR of 6.20% during the forecasting years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries reviewed in the region comprise:
•
United Arab Emirates
•
Saudi Arabia
•
Turkey
•
South Africa
•
Rest of Middle East & Africa
In the last few decades, the Middle East and
African region have spent more on healthcare. The increase in healthcare
expenditure can be attributed to the combination of costly health technologies
and shifts in lifestyle. Further, the region is strengthening its supply chains
by making delivery routes shorter and more diverse. Hence, as mentioned above,
these factors are creating novel opportunities for the pharmaceutical supply
chain management market.
Our estimates indicate that the United Arab Emirates dominates the
pharmaceutical supply chain management market in the region. The pharmaceutical manufacturing sector is
booming, significantly boosting the country’s economy. This promotes the
ability to be self-sufficient and reduces the need for imported medical
products. It is also home to many global pharmaceutical companies, such as
Johnson & Johnson. In addition, with strong infrastructure, significant
investment, and government support, the pharmaceutical sector in the country is
well-positioned for prosperous advancement.
Likewise,
Turkey has integrated cutting-edge IT solutions into its healthcare system. For
example, the Ministry of Health (MoH) employs its software developers to
develop various IT tools for the healthcare system and collaborates with
external software companies. This comprehensive approach ensures thorough
documentation in electronic health records (EHR). Furthermore, as the demand
for healthcare products surges, healthcare facilities proactively embrace
supply chain management solutions to optimize operational efficiency and foster
streamlined processes.
Managed services are used in pharmaceutical
supply chain management, where tasks are outsourced to third-party providers.
It includes demand planning, inventory control, logistics, and more.
Collaboration between pharmaceutical companies and providers increases
efficiency, reduces costs, and integrates advanced technologies such as AI and
big data analytics for optimization.
The
pharmaceutical supply chain management market is classified into deployment
mode and solution.
The component segment is further classified into solution and service. The
service segment includes managed services and professional services.
The
key companies thriving in the market comprise Jump Technologies Inc, Oracle Corporation, Cardinal
Health Inc, Arvato Group, Tecsys Inc, SAP SE, Manhattan Associates Inc,
and Terso Solutions Inc.
Manhattan Associates Inc is a software solutions
provider specializing in supply chain, warehousing, and omni-channel
operations. It develops, implements, and maintains software to manage various
aspects of the supply chain ecosystem, connecting manufacturers, retailers, and
suppliers. Moreover, its offerings include software, services, and hardware
that enable efficient data exchange and stakeholder coordination. Manhattan
Associates operates in various regions, including the Middle East and Africa.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2023-2030
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the pharmaceutical
supply chain management market revenue growth in the Middle East and Africa and
its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the Middle
East and Africa pharmaceutical supply chain management market’s growth during
the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHT
2.2.1. EMBRACING
MODERN INVENTORY SOLUTIONS FOR DECENTRALIZED SUPPLY CHAIN
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE S
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
BUYING IMPACT ANALYSIS
2.5.1. COMPETITIVE
PRICING
2.5.2. INTEGRATION
CAPABILITIES
2.5.3. INVENTORY
MANAGEMENT
2.5.4. ANALYTICS
AND BUSINESS INTELLIGENCE
2.5.5. SECURITY
AND DATA PRIVACY
2.6. KEY
MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT
LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISING
ADOPTION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
2.7.2. IMPLEMENTATION
OF GS1 STANDARD
2.7.3. GROWING
EMPHASIS ON REDUCING HEALTHCARE EXPENDITURE
2.7.4. INCREASING
DEMAND FOR PHARMACEUTICAL PRODUCTS
2.7.5. CONCERN
REGARDING DRUG COUNTERFEITING
2.8. MARKET
CHALLENGES
2.8.1. REGULATORY
CHALLENGES IN HEALTHCARE DATA EXCHANGE
2.8.2. HIGH
COST OF SUPPLY CHAIN MANAGEMENT SOFTWARE
2.8.3. SCM
SOFTWARE ENCOUNTERS TECHNICAL ISSUES
2.8.4. PRIVACY
CONCERNS ARISING IN SCM LINKS
2.9. MARKET
OPPORTUNITIES
2.9.1. ADVANCEMENTS
IN CLINICALLY INTEGRATED SUPPLY CHAINS
2.9.2. ENHANCING
QUALITY AND CARE WITH ADVANCED SUPPLY CHAIN TECHNOLOGIES
3. MIDDLE
EAST AND AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COMPONENT
3.1. SOLUTION
3.1.1. TRANSPORTATION
MANAGEMENT SYSTEM
3.1.2. PLANNING
AND ANALYTICS
3.1.3. WAREHOUSE
AND INVENTORY MANAGEMENT SYSTEM
3.1.4. PROCUREMENT
AND SOURCING
3.1.5. MANUFACTURING
EXECUTION SYSTEM
3.2. SERVICE
3.2.1. PROFESSIONAL
SERVICES
3.2.2. MANAGED
SERVICES
4. MIDDLE
EAST AND AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY DEPLOYMENT
MODE
4.1. ON-PREMISE
4.2. CLOUD-BASED
5. MIDDLE
EAST AND AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COUNTRY
OUTLOOK
5.1. COUNTRY
ANALYSIS
5.1.1. UNITED
ARAB EMIRATES
5.1.1.1. UNITED
ARAB EMIRATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST &
PROSPECTS
5.1.2. TURKEY
5.1.2.1. TURKEY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.3. SAUDI
ARABIA
5.1.3.1. SAUDI
ARABIA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.4. SOUTH
AFRICA
5.1.4.1. SOUTH AFRICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.5. REST
OF MIDDLE EAST & AFRICA
5.1.5.1. REST
OF MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
FORECAST & PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. MCKESSON
CORPORATION
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.1.3. KEY
STRENGTHS
6.1.4. KEY
CHALLENGES
6.2. INFOR
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ORACLE
CORPORATION
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. CARDINAL
HEALTH INC
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. TECSYS
INC
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. SAP SE
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. JUMP
TECHNOLOGIES INC
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.8. MANHATTAN
ASSOCIATES INC
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. TERSO
SOLUTIONS INC
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. ARVATO
GROUP
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK,
2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: MAJOR FACTORS
CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 6: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030
(IN $ MILLION)
TABLE 7: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030
(IN $ MILLION)
TABLE 8: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN
$ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE 10: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK,
2023-2030 (IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2022 &
2030 (IN %)
FIGURE 3: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2022 &
2030 (IN %)
FIGURE 4: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION
MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING AND
ANALYTICS, 2023-2030 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE AND
INVENTORY MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT AND SOURCING,
2023-2030 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING
EXECUTION SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 9: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2022 &
2030 (IN %)
FIGURE 10: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 11: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 12: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2022
& 2030 (IN %)
FIGURE 13: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN
$ MILLION)
FIGURE 14: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030
(IN $ MILLION)
FIGURE 15: MIDDLE EAST AND
AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2022
& 2030 (IN %)
FIGURE 16: UNITED ARAB
EMIRATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: TURKEY
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 18: SAUDI ARABIA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 19: SOUTH AFRICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE
20: REST OF MIDDLE EAST & AFRICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT
MARKET 2023-2030 (IN $ MILLION)